The efficacy, stability and safety study of self-assembled cervical cancer-targeted novel drug carrier derived from pullulan conjugate
- At: 2011 FIP Congress in Hyderabad (India)
- Type: Poster
- By: HONGBO, Tang (Beijing Obstetrics And Gynecology Hospital, Capital Medical University, Beijing, China)
- Co-author(s): Xin, Feng (Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China)
Qiqing, Zhang (Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, Peking, Tianjin, China)
To evaluate the potential of folate conjugated pullulan acetate (FPA) as a cervical cancer targeted nanocarrier. Folate conjugated pullulan acetate nanoparticles (FPANs) and Epirubicin-loaded FPANs (FPA/EPI) were prepared by dialysis method. Various physicochemical properties of FPA and FPA/EPI including size, surface charge and morphology were.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.